CANDI CARNEY: Open Payments
NPI 1356710263 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,599 in 160 payments from 19 companies in 2025. Trend: 2023 $2,298 · 2024 $4,075 · 2025 $2,599
Food & beverage: $2,451Education: $148
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $293 |
| Regeneron Healthcare Solutions, Inc. | 12 | $286 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $253 |
| GENZYME CORPORATION | 10 | $220 |
| LEO Pharma Inc. | 17 | $215 |
| Janssen Biotech, Inc. | 15 | $210 |
| Galderma Laboratories, L.P. | 20 | $196 |
| Arcutis Biotherapeutics, Inc. | 16 | $193 |
| PFIZER INC. | 16 | $178 |
| UCB, Inc. | 4 | $99 |
Products named: DUPIXENT, TREMFYA, Zoryve, CIBINQO, ADBRY, NEMLUVIO, SKYRIZI, Bimzelx.
Industry payments across TX — which companies pay providers there.
